Sage Therapeutics Inc (SAGE)

5.38 -0.36 (-6.27%) USD  |  NASDAQ  |  Nov 14, 16:00
5.38 0.00 (0.00%) After-Hours: 20:00
More

Sage Therapeutics Cash and Short Term Investments (Quarterly): 569.15M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
September 30, 2024 569.15M
June 30, 2024 646.79M
March 31, 2024 717.01M
December 31, 2023 753.18M
September 30, 2023 876.05M
June 30, 2023 1.003B
March 31, 2023 1.130B
December 31, 2022 1.272B
September 30, 2022 1.394B
June 30, 2022 1.514B
March 31, 2022 1.625B
December 31, 2021 1.742B
September 30, 2021 1.843B
June 30, 2021 1.911B
March 31, 2021 2.004B
December 31, 2020 2.100B
September 30, 2020 668.54M
June 30, 2020 756.52M
March 31, 2020 872.76M
December 31, 2019 1.008B
September 30, 2019 1.122B
June 30, 2019 1.237B
Date Value
March 31, 2019 1.351B
December 31, 2018 922.78M
September 30, 2018 1.021B
June 30, 2018 1.092B
March 31, 2018 1.084B
December 31, 2017 518.85M
September 30, 2017 243.45M
June 30, 2017 285.93M
March 31, 2017 342.56M
December 31, 2016 397.48M
September 30, 2016 431.27M
June 30, 2016 272.30M
March 31, 2016 299.68M
December 31, 2015 186.75M
September 30, 2015 204.88M
June 30, 2015 224.23M
March 31, 2015 113.16M
December 31, 2014 127.77M
September 30, 2014 136.73M
June 30, 2014 49.13M
March 31, 2014 55.42M
December 31, 2013 8.066M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

569.15M
Minimum
Sep 2024
2.100B
Maximum
Dec 2020
1.220B
Average
1.069B
Median

Cash and Short Term Investments (Quarterly) Benchmarks

Outset Medical Inc 175.63M
Biogen Inc 1.699B
Johnson & Johnson 20.30B
Lifecore Biomedical Inc 5.52M
Organon & Co 763.00M